Manage Your Liver
Q:

New type of fatty liver diseases found in people who are not obese

New type of fatty liver diseases found in people who are not obese
A:

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are common liver diseases. They occur in people who drink little or no alcohol at all and are considered to be consequences of obesity. 

 

However, “not obese” does not equal “no NAFLD / NASH”, since NAFLD may not be linked with obesity in some cases. Fatty liver disease may also develop in non-obese people. The terms “lean NAFLD” and “lean NASH” are used to describe fatty liver in patients who are not overweight or obese.  Researchers also proposed the terms “nonobese fatty liver disease (NOFLD)” and “nonobese steatohepatitis (NOSH)” for this type of patients.

 

How dangerous is NOFLD & NOSH?

 

NOFLD and NOSH occur in normal weight patients, as defined by the standard parameter of body mass index (BMI). According to a study, NAFLD was reported in up to 10% of lean patients in the US. Worldwide, the prevalence of fatty liver was around 50-70% in obese persons and 15-20% in non-obese persons.

 

It is important to identify these lean fatty liver disease patients as some studies suggest that this condition is associated with a worse metabolic and liver profile than obesity-related fatty liver disease. Lean NAFLD was also more strongly linked with diabetes, hypertension, and metabolic syndrome than the common obese NAFLD we know.

 

In addition, several studies have suggested that nonobese patients with fatty liver disease have more severe inflammation, higher prevalence of severe liver fibrosis and higher mortality than obese patients.

 

Take preventive measures

The standard treatment recommendation for NAFLD patients is healthy diet and exercise. However, for NOFLD patients who are of normal weight and yet are found to have steatohepatitis, what is the most beneficial treatment?

 

Apart from the standard recommendation – exercise and diet modification, preventive strategies are also important for normal-weight patients with fatty liver. Taking preventive measures to protect liver cells can help to prevent inflammation caused by the excess amount of fat in the liver. As inflammation is the major cause of liver damage, fibrosis and cirrhosis; stopping or preventing inflammation is the key to protecting the liver and reducing the risk of severe liver diseases in the long term.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Being the most serious form of liver disease, liver cancer is on the rise globally. While we have always known that liver cancer doesn’t develop overnight, there have not been many studies that investigate the potential risks for liver cancer for patients with liver diseases. According to a recent research conducted by the AGA Institute, it was found out that non-alcoholic fatty liver disease (NAFLD) patients have a higher risk of developing a dangerous liver cancer called hepat
A:
Non-alcoholic fatty liver disease (NAFLD) is gradually becoming a global epidemic. The number of adults, and even children, being diagnosed with this silent killer skyrocketed like never before. Due to the broad spectrum of liver conditions that NAFLD includes (fatty liver and NASH), a recent research suggests that personalized risk prognosis and individualized treatment is needed in order to treat NAFLD more effectively.   Various health problems complicate t
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.